Delivery Order SPE2DB22D3016-SPE2DB25FBEQ4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary operational hub for federal...
- The Defense Logistics Agency awarded a $107,643.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $71,762.52 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product for military healthcare systems. This firm fixed-price delivery order, awarded on July 28, 2025, carries an ultimate completion date of August 18, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies valued at $23,920.84 on July 29, 2025, with completion expected by August 19, 2025. The delivery order is for DARZALEX FASPRO 1,800mg-30,000 15ml units, a specialty medication used in hematologic malignancy treatment. This contract employs firm fixed price terms with no set-aside designation, indicating competitive award based on open competition. Performance will occur at...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $95,683.36 under a firm fixed price contract type, with an ultimate completion date of August 29, 2025. The award was made on August 8, 2025, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency has awarded a delivery order valued at $59,802.10 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 IU 15ml pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml, a specialty pharmaceutical product. This firm fixed price delivery order, with a completion date of September 9, 2025, represents a non-competitive, non-set-aside award for a critical oncology medication supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at approximately $59.8K to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEQ4Delivery Order
The Defense Logistics Agency awarded a $17,940.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical supply. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of medical product deliveries to the Defense Logistics Agency's Medical Supply Chain. The company's federal contracting history demonstrates consistent capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This particular award involves the delivery of a specialty oncology pharmaceutical product to support defense healthcare requirements, reflecting the vendor's established role in providing specialized medical commodities to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 8/12/25 |